JPS58144746A - Separation of serum and blood clot - Google Patents

Separation of serum and blood clot

Info

Publication number
JPS58144746A
JPS58144746A JP2859682A JP2859682A JPS58144746A JP S58144746 A JPS58144746 A JP S58144746A JP 2859682 A JP2859682 A JP 2859682A JP 2859682 A JP2859682 A JP 2859682A JP S58144746 A JPS58144746 A JP S58144746A
Authority
JP
Japan
Prior art keywords
blood
serum
inorganic substance
separation
adsorbent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2859682A
Other languages
Japanese (ja)
Inventor
Kazuhiko Kamiyoshi
和彦 神吉
Hideo Anraku
秀雄 安楽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Priority to JP2859682A priority Critical patent/JPS58144746A/en
Publication of JPS58144746A publication Critical patent/JPS58144746A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/491Blood by separating the blood components

Abstract

PURPOSE:To improve the separation of serum and blood clot while the time required for the clotting of blood is reduced significantly by providing blood with an adsorbing inorganic substance subject to the absorption quantity of linsed oil, BET specific surface area and specific resistance within a specified range. CONSTITUTION:Blood is separated centrifugally into serum and blood clot. Prior to it, the blood is provided with an adsorbing inorganic substance subject to the absorption quantity of linsed oil of 20-40ml/100g, the BET specific surface area 5,000-30,000cm<2>/g and the specific resistance below 1X10<10>OMEGAcm at the surface temperature. The adsorbing inorganic substance herein used is, for example, fine silica powder.

Description

【発明の詳細な説明】 本発明はmsと血餅との分離方決に関し、詳しくは被検
者の全一試料から遠心分−によ)−清と血餅を分離する
方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for separating ms and blood clots, and more particularly to a method for separating serum and blood clots from a whole sample of a subject (by centrifugation).

近年、検査技術O目ざましい進歩と相俟って、―清生化
学検査、−清免疫学検査、血球検査等の血液検査が成〈
普及し、病気予防中早期診断に大龜(貢献するに至って
いる。血清検査は、−線検査の主体をなしており、検査
に要する―清は通常、血液検査用容−KIl取しえ一波
t−巖−させえ後、遠心分離によって%死重の異なる―
餅(フィブリンと―球が混合したゲル橡塊状物)から分
離している。
In recent years, with the remarkable progress in testing technology, blood tests such as biochemical tests, immunological tests, and hematology tests have become possible.
It has become popular and has contributed greatly to the prevention and early diagnosis of diseases. Serum tests are the main component of -line tests, and the -KIL required for testing is usually the capacity for blood tests. After wave t-wao-ing, % dead weight varies depending on centrifugation.
Separated from rice cake (gel mass mixed with fibrin and spheres).

そして−掖を遠心分離操作に付して血清と血餅とに分け
た費、血11部分tピヘットで吸上けえり、デカンテー
シ璽ンにより採取することが行゛なわれていす、―溝部
分0111&は、血酸O凝圃を待って行なわれるが J
ll固迄にかなりの時−を必II七し、迅速に検査を宍
施できない点が間層となっている。
Then, the blood is centrifuged to separate serum and blood clots, 11 parts of the blood are sucked up with a pipette, and collected with a decantation bottle.-The groove part 0111& is performed after waiting for blood acid O coagulation.
The problem is that it takes a considerable amount of time to complete the test, and testing cannot be carried out quickly.

量4h自漉S固時簡が短かいとされる夏うス製自績検査
#!ISSでさえ、血液を注入し友後凝−に至る九に4
0乃至60分を必要とし、合置柵脂製血液検査摺審11
KIりては―腋amする逃に4時崗の放置を必要とする
Quantity: 4 hours Self-sweeping S hard time sheet is said to be short. Even on the ISS, blood was injected and blood was injected into the air to cause coagulation.
It takes 0 to 60 minutes, and it takes 11 minutes for blood test screening.
KI Rite needs to be left alone at 4 o'clock in order to escape from the armpits.

従来の血清とm炉上の分離方決(おける更に錬の聞ff
1r′i、JlmLえ全廊を遠心分離等の手段によって
比重の興なる血清と血餅に相分離させて、検査Kl用す
る純粋1に一滴を採取するに際し、−瞬の分離性が概し
て不良であることである。
Conventional serum and separation method on m furnace
1r'i, JlmL When the whole passageway is phase-separated into serum and blood clots of high specific gravity by means such as centrifugation, and a drop is collected in pure 1 for test Kl, the separability of the moment is generally poor. It is to be.

このためピイットで吸上けるにも赤−球を@上けないよ
うに神経を使わなければならないし、デカンテーション
O場合にも赤―球が入9込まないように細心の注意を必
要としてい九が、殆んどの場合赤−球が混入し、臨昧検
査値に影響を及)丁した秒、再遠心分離操作を必要とす
る等O欠点があった。
For this reason, you have to be careful not to let the red ball go up when you suck it up with Piit, and you have to be very careful not to let the red ball go in when you decant. However, in most cases red spheres were mixed in, which affected the critical test values), and there were other drawbacks such as the need for recentrifugation.

本発明にかかる欠点を解消し、IIi液凝−に要するI
?mt大−KIli縮させると共に一清歇分と劇餅歇分
を良好に分離する力泳t#I供することを1鈎とする。
The drawbacks of the present invention are solved, and the I required for liquid coagulation is
? One of the hooks is to provide force swimming t#I that reduces mt large-KIli and satisfactorily separates ichisei kibu and gekimochi kibu.

本発明011Fi、−at達心分離操作に付して―清と
血餅とに分離する方&1ICI?いて、−線中にアマニ
油啜油量が鵞・乃至46m/100f。
The present invention 011Fi, - At the heart separation operation - How to separate serum and blood clot & 1 ICI? In the - line, the amount of linseed oil and sour oil is 0.46m/100f.

BETjt麦向積がi・・・乃至3・・・・−/f。BET jt barley product is i... to 3...-/f.

比抵抗が常11においてI X 1010Ω・1皐下で
ある吸着性無機物を存在させておくことを特徴とする、
血清と血餅との分離方法に存する。
characterized by the presence of an adsorbent inorganic substance whose specific resistance is usually less than I x 1010 Ω·1 at 11;
It consists in the method of separating serum and blood clots.

次に零発明―清と血餅との分離方法について更に#、細
に説明する。
Next, the zero invention - method for separating serum and blood clots will be explained in more detail.

被検者の全血試料を遠心分離操作に付して血清と血餅を
分離するために、血液は検査用容I!に入れられるが、
検査MIsII!の素材としては、1可■性樹脂、sI
硬化性楠脂、変性天#&楠脂、ガラス等Oいずれもが使
用てきる。
In order to centrifuge the subject's whole blood sample to separate serum and clots, the blood is placed in a test volume I! Although it can be put in
Inspection MIsII! The material is 1 flexible resin, sI
Hardenable camphor resin, modified natural camphor resin, glass etc. can all be used.

そして検査用客器に入れられた血液中Kl1着性。and Kl1 adhesion in the blood placed in the test container.

無機物を存在させておく*lj着性無性無機物ては、吸
着剤として使用されているような無機物、例えばガラス
、シリカ、カオリン、セライト、ペンナナイト等O水不
嬉性の無機質微粉末がこれに該当する。
Preserve an inorganic substance *ljAdhesive inorganic substance is an inorganic substance used as an adsorbent, such as glass, silica, kaolin, celite, pennanite, etc.O water-resistant inorganic fine powder. Applicable.

叉、吸着性無機物は粒径がsO−以下であって、平均粒
をか10μ以下のものを使用するのが好適である。そし
て特に血液JI!一時−1短縮させるに有効1に吸着性
無機物はシリカであり、と9分は無[形猷分を鵞O重量
%以上會有する多孔性のシリカがすぐれえ#果を発揮す
る。
It is preferable to use adsorbent inorganic substances having a particle size of sO- or less and an average particle size of 10 μm or less. And especially Blood JI! The adsorptive inorganic substance effective in reducing the time by -1 is silica, and the adsorbent inorganic material is effective for reducing the time by 9 minutes.

かかる吸着性無機物は、−績と接触し良場合に―#I鹸
−因子の活性化を促進し、叉自小板の凝集を促がす作用
を何する。しかしながら吸着性無機物が一液衆國促處作
用を効果的に発揮するためKは、アマニ油吸油量、BI
ETjt麦面積値、丸面積値が一足の範囲内に存在する
ことがロオされる。
Such adsorptive inorganic substances act to promote the activation of the #I factor and promote the aggregation of the platelets when they come into contact with the particles. However, in order for adsorbent inorganic materials to effectively exert a one-liquid concentration promoting effect, K is linseed oil absorption, BI
It is determined that the ETjt barley area value and the round area value are within the range of one foot.

アマニ油吸油魚及びBIT比表向積儲は、吸着性無II
I黴粉末の表面積の程度を表わし、叉麦面横は吸着性無
機物O!する!1面孔l[の程度とr14達するので、
@曲量及び比表面積によって麦l孔隙OIM度を知るこ
とができる。そして本発明における吸着性無機物は、ア
マニ曲吸油量が20−40m/10・9%B11Tk、
表面積値が5ooo〜300(11)m/Fであるもの
が使用される。
Linseed oil-absorbing fish and BIT ratio surface accumulation are non-adsorbent II.
I represents the surface area of mold powder, and the horizontal side of the mold is an adsorbent inorganic substance O! do! Since the degree of one-sided hole l[ and r14 are reached,
@The degree of pore OIM can be determined by the amount of curvature and specific surface area. The adsorptive inorganic material in the present invention has a flaxseed oil absorption amount of 20-40 m/10.9% B11Tk,
Those having a surface area value of 5ooo to 300(11) m/F are used.

アマニ油吸油量は日本工業規格に−1101に準拠して
自足される値を示し、吸着性無機物1乃zsrtガtx
板(約zsoxzsoxsm)にとシ、アマ=gtビユ
レットから9臆ずり鋳記試料の中央に滴下し、その都度
全体tヘラて充分に線参合わせ、前記試料がアマニ油の
一滴で急setやわらかくなりガクス板に粘りつく直m
tm点としそれ迄に使用したアマニ油の量を求め%試料
1009に対するアマニ油の4歇を以ってアマニ油吸油
凰とする。
Linseed oil absorption shows a self-sufficient value in accordance with Japanese Industrial Standards -1101, and absorbent inorganic substances 1~zsrtgatx
Place a drop of flax oil on a plate (approximately 100 ml) in the center of the casting sample, and each time mix thoroughly with a spatula until the sample suddenly becomes soft with a drop of linseed oil. Naomi sticks to the Gakusu board
The amount of linseed oil used up to the tm point is determined, and the 4 cycles of linseed oil for % sample 1009 are taken as the linseed oil absorbent.

111ETjt麦面積値は、Brt+nauer−Km
mett −Teller  Kよりて提案され多分子
m吸着理論から求められる値であり、その理論社%J1
)酊−alof  American  Chemic
al  5ociety  IJL。
111ETjtWheat area value is Brt+nauer-Km
This is a value obtained from the multimolecular adsorption theory proposed by Mett-Teller K, and the theoretical company %J1
) drunkenness-alof American Chemic
al 5ociety IJL.

309(193g)ill、!611意(1917)4
1に&&%て詳説されている。
309 (193g)ill,! 611 (1917) 4
1. &&% is explained in detail.

BET比貴面積値は、吸着性無機物の表面に吸着される
気体の吸着量、その時の平衡圧、吸着ガスO飽和蒸気圧
から単分子層上して麦mをおおい切る気体量を求め、こ
れに吸着気体分子〇平均断面積1*じて算出され良値を
指すも〇てあり、吸着気体としては11JIlガス、酸
素ガス、アルゴンガス、メタンガス等が使用される。そ
してこの方法vc1れば、アマニ油吸油量の測定によっ
てrilli1足できない細孔を含めた表向積値が#1
足される。
The BET specific area value is determined by calculating the amount of gas that will cover the wheat m in a monomolecular layer from the amount of gas adsorbed on the surface of the adsorbent inorganic material, the equilibrium pressure at that time, and the saturated vapor pressure of adsorbed gas O. A good value is calculated by calculating the average cross-sectional area of the adsorbed gas molecules by 1*, and 11JIl gas, oxygen gas, argon gas, methane gas, etc. are used as the adsorbed gas. If this method vc1 is used, the surface area value including the pores that cannot be added by one rilli by measuring the linseed oil absorption amount is #1.
It is added.

血欲#1iSIKIIしては、第Xll因子、すなわち
倹触因子が活性化されるが、このためKFi具物ik向
上Kl!IXII因子、プレカリクレイン、高分子キニ
ノーゲンの3種の物質が錯体を形成して吸着されること
が必要であり、これらの一つ又は二つが欠けえ状1で0
1111#i活性化に至らないとされている。ところで
、血液*ii促進作用を期待して吸着性無機物を使用し
た場合に、表面積が非常に大き1に4hのであると、吸
着性無機物の表面上には錯体を形成しない状−での第X
1llfi子、プレカリクレイン、高分子キニノーゲン
の吸着の割合が高まることになり、言い換えると、第X
ll因子の活性化に必要な三者の錯体形成割合は減少す
ることKなり、かえって血液絵−促進作用は減殺される
ことKなる。
Blood desire #1iSIKII activates factor Xll, that is, the sensitization factor, which increases KFi ingredients ik! It is necessary that three substances, factor IXII, prekallikrein, and polymeric kininogen, form a complex and be adsorbed, and one or two of these substances can
1111#i is said to not be activated. By the way, when an adsorbent inorganic substance is used in the hope of promoting blood*ii, if the surface area is very large (1 to 4 h), the X
The adsorption rate of 1llfi, prekallikrein, and polymeric kininogen will increase, in other words,
The rate of complex formation among the three components necessary for activation of factor ll is reduced, and the blood picture-promoting effect is on the contrary diminished.

また逆に@糖性無機物の表面積が小さすぎると、Jll
固因子O1j@0確亭が小さくなり、血妓凝因促遮作m
t期待することができなくなる。このために本発明にお
ける吸着性無機物はアマニ油吸油量が!O〜40gIt
/100f、BET比貴面表面#S OOO−3000
0txl/fit)範l1IO1k向横を有する−のと
される。
On the other hand, if the surface area of the sugar mineral is too small, Jll
The solid factor O1j@0 decreases, promoting and blocking hemocoagulation.
You won't be able to expect much. For this reason, the adsorbent inorganic material in the present invention has a high absorption amount of linseed oil! O~40gIt
/100f, BET ratio surface #S OOO-3000
0txl/fit) has a range l1IO1k direction and width.

又、本発明における吸着性無機−〇比抵抗値はlXl0
IOΩ・1以下、より好ましく tl 5 X 104
Ω・1以下であるものが使用される。比抵抗値は電気伝
導度の逆数であり、常温における値である。
In addition, the adsorbent inorganic specific resistance value in the present invention is lXl0
IOΩ・1 or less, more preferably tl 5 × 104
A material with a resistance of Ω・1 or less is used. The specific resistance value is the reciprocal of electrical conductivity, and is the value at room temperature.

素線が異物に接触すると、−峡凝一堝象に先立ってアル
ブミン、グロブリンや種々O血鍍凝固因子等の蛋白質が
直ちに異物表向へ吸着し、そのIIO蛋白質分子のコン
7オーメーシ扇ンの変化が、引続いて生ずる生化学反応
に様々11影響を及ばす、特に酵素反6である龜#l[
#固因子0活性化機構は大11な影響を受は場合によっ
てはlI!固機能を損なう。
When the wire comes into contact with a foreign object, proteins such as albumin, globulin, and various blood coagulation factors are immediately adsorbed to the surface of the foreign object, prior to the formation of isocoagulant, and the concentration of the IIO protein molecules increases. The changes have a variety of effects on the subsequent biochemical reactions, especially the enzyme reaction 6.
#The fixed factor 0 activation mechanism is greatly influenced by lI! Impairs solid function.

叉、大きなコンフォーメーションの変化を生じえ黴看グ
Oプリン、アルブミンO上に付着しえ皿小&tl異常な
溶I11責形をきたし、重合析出したフィブリン鎗が吸
着性無機物に強く固着するという現象を引き起こす、徒
者の現象が血清採収を目的とする客−内で生ずる七、遠
心分離を行なっても、血餅と血清とに分離せず、その目
−jt一連成することができなくなる。
In addition, a large conformational change occurs, causing the mold to adhere to the purine and albumin O, resulting in an abnormally small and tl shape, and the phenomenon in which the precipitated fibrin sticks strongly to the adsorbent inorganic material. 7. Even if centrifugation is performed, blood clots and serum will not be separated, and the blood clots will not be able to form a blood clot and serum. .

伽白質oコン7オーメーレヲンの変化#i吸着性無機物
と蛋白質問の疎水性相互作用、水素結合性相互作用、静
電鈎相互作用等の様々な相互作用の結果生ずるが、この
うち静電鈎相互作1@については比較#I専電性の高い
吸着性無機物を用いると緩和される。すなわち、蛋白質
の持つ極性基鮮によや吸着性無機物中には、それらKt
3した分布1袴つ訳極子毫−メン)IIが誘起されるわ
けであるが、吸着性無機物が非導電性であれは導電性の
場合に比して応答性が悪く1にや、*1klKlj着し
ている蛋白質の有すゐ電位分布と吸着性無機物の有する
電位分布とは相互に整合性1欠き、これが蛋白質に局所
的で不均一な歪/ 与を生じさせコン7オーメーシ冒ンt)f 化へとり1
kがる。*りで吸着性無機物が導電性1有することは、
蛋白質と吸着性無機物と0IIO電位分*O整合性を保
持し、蛋白質Oコン7オーメーシ璽ンO変化を防止する
ために必要で小る・こ〇九めに本発明における吸着性無
機物は、比抵抗値がI X 10toΩ・α 以下のも
のとされるOである。
Changes in the white matter o-con 7 Omeleon #i These occur as a result of various interactions between adsorbent inorganic substances and proteins, such as hydrophobic interactions, hydrogen bonding interactions, and electrostatic hook interactions. Among these, electrostatic hook interactions Concerning work 1@, comparison #I can be alleviated by using an adsorbent inorganic material with high exclusive electric properties. In other words, Kt
However, if the adsorptive inorganic substance is non-conductive, the response will be worse than if it is conductive, and *1klKlj The potential distribution of the adhering protein and the potential distribution of the adsorbing inorganic substance are not consistent with each other, and this causes local and non-uniform strain on the protein, resulting in contamination. f conversion 1
k-garu. *The fact that an adsorbent inorganic substance has conductivity 1 means that
The adsorbent inorganic substance in the present invention has a relatively high O has a resistance value of I x 10toΩ·α or less.

吸着性無機物tm液中に存在させる丸めには。For the rounding of adsorptive inorganic substances present in tm liquid.

例えば検査m容器内0IkI腋中に吸着性無機物を直後
添加してもよいし、本−の分散媒に分散さ−tた4ot
滴下してもよいし、比重がLO4〜LOIli度の担体
に付着させ九もot添加してもよい。
For example, an adsorbent inorganic substance may be immediately added to the axillary part of the test container, or the adsorbent inorganic substance may be added immediately after the adsorption inorganic substance is dispersed in the dispersion medium.
It may be added dropwise, or it may be added by adhering it to a carrier having a specific gravity of LO4 to LOIli.

血液中Kll在さぜる吸着性無機物Otは血液量10g
l1li)sxio−・f乃至1sXI@””’fで小
るOが好ましく 、S X I Q −@ yよりも少
量であると一波il−促進作用が低下し、叉5Xle−
雪tx*も多量であると―線検査twi害するおそれが
出てくる。
The adsorbent inorganic substance Ot present in blood is 10g of blood.
l1li) sxio-・f to 1sXI@""'f is preferable, and if the amount is smaller than S
If there is a large amount of snow tx*, there is a risk of damaging the line inspection twi.

本発明方法によれば、吸着性ll1lI物によって―献
lIk固因子が迅速Kf!5性化され、血献豪−に要す
る時間が著しくamされると共に血清と血餅との分離が
客14に行なわれ、分IIl採取され大自浦中に伐与フ
ィブリン中血餅区分が混入する問題も解消され、更にt
i自餅隈分の収縮が充分に進行する結果、血清の収量が
増大する。
According to the method of the present invention, the adsorbable IlIl substance rapidly converts the Kf! 5 sexes, the time required for blood donation was significantly increased, and separation of blood serum and blood clots was carried out in 14 days. The problem of
i The yield of serum increases as a result of the sufficient contraction of the rice cake.

舅11 吸着性無機物として、アマニ油吠油量が30s//1G
Of、BETJtjllli積がL 2 x lO’t
d/f。
Father-in-law 11 As an adsorbent inorganic substance, the amount of linseed oil is 30s//1G
Of, BETJtjllli product is L 2 x lO't
d/f.

比抵抗が14!1X104Ω・α、平均粒径が翫5μm
のシリカ微粉末を用い、10重量%の水分散液tl1g
lした。
Specific resistance is 14!1X104Ω・α, average particle size is 5μm
Using fine silica powder, 1g of 10% by weight aqueous dispersion
I did it.

次いで、(イ)10dl13ガラス製検査用客器、(ロ
110−川ポリエチレン製検査用sm、(ハ)10d用
ポリメチルメタクリレ一ト製検査用客Sを用意し、大々
の検査容l!に入断S−を8dずつlimし、直ちに―
記水分欽me亀6Isfずつ滴下して20℃で放置しえ
Next, prepare (a) a 10 dl 13 glass test container, (b) a 110-meter polyethylene test container, and (c) a 10 d polymethyl methacrylate test container S, and make a large test volume l. !Lim S- by 8d and immediately-
Add 6 Isf of water dropwise and leave at 20°C.

全白が完全に流動しなくなる迄に要し九時1llt血液
#一時周として測定した。血液凝li!iI後、直ちK
100O11転/分で5分間遠心分離を行ない、血清分
離状fiを観察すると共に上N血清をピペットでIIT
xシ、その量を血清収量とした・そ0結at麦lO%1
Is141t)lIIK示f@実施例意 吸着性無機物として、アマニ油吸油愈が30d/l・O
f%BKTjt表面積がL!X104、比抵抗が!6X
104Ω・1、平均粒径が翫2メ鯛Oシリカ黴粉末を用
い、直径3■、厚さ1MO円筒状ポリエチレン樹脂ベレ
ット(硫酸パ9?五を添加して比重toolに調整し九
−〇)K*布し、付着させた。
The time required for all the blood to stop flowing was measured as 9 o'clock and 1 llt blood #1 cycle. Blood clot li! Immediately after iI
Perform centrifugation at 100O11/min for 5 minutes, observe serum separation, and pipette the upper N serum into IIT.
x, the amount was taken as the serum yield・So0at wheat 1O%1
Is141t) lIIK Indication f@Example As an adsorbent inorganic substance, linseed oil absorption capacity is 30 d/l・O
f%BKTjt surface area is L! X104, specific resistance! 6X
A cylindrical polyethylene resin pellet with a diameter of 3 mm and a thickness of 1 MO was prepared using silica mold powder of 104Ω・1 and an average particle diameter of 2 mm (adjusted to a specific gravity of 9-0 by adding 9-5% of sulfuric acid). K* cloth and attached.

次いで(イ)1(lsf用ガツガ2ス製検査用11is
口)l・−用ポリエチレン製検査用容器(ハ)l・−M
IIダメチルメタクリレート製検査Mill器tjII
童し、犬身O検査Flllllに入断**ts−ずつ採
幽し、直ちに一記Oシリカ黴粉末を付着させえポリエチ
レン柵脂ベレットtlfずつ添加し、!61Cで放置し
え。
Next (a) 1 (11is for inspection made by Gatsuga 2S for LSF)
Polyethylene test container for l/- (c) l/-M
II damethyl methacrylate inspection mill tjII
When the dog was born, the dog was inspected and taken into custody one by one, and immediately silica mold powder was attached to it, and a polyethylene fence pellet TLF was added to it. Leave it at 61C.

二〇場合の一波Jllll1局、血清分離状鰺、幽騎収
jlk&lの実施例2の欄に示す。
It is shown in the column of Example 2 of 20 cases of one wave Jllll1 station, serum isolated mackerel, and Yuuki Jlk&l.

比較例1 (イ)10−用ガラス製検査用客器、(→1〇−用ポリ
エチレン製検査用容器、(ハ)l〇−用ポリメチルメタ
クリレート製検査用11Iを用意し、大々の検量用容器
に入断−―を8−ずつ採血し20℃で放置し友。
Comparative Example 1 (A) A test container made of glass for 10-, a test container made of polyethylene for (→10-), and (c) a test container 11I made of polymethyl methacrylate for 10- were prepared and a large scale calibration was carried out. Collect blood from 8 incisions into a container and leave it at 20°C.

この場合の血液凝固時間、−清分離状l、血清収凰t−
表1の比較例10111に示す。
Blood coagulation time in this case, -separation form 1, serum collection t-
It is shown in Comparative Example 10111 in Table 1.

比較4#12 吸着性無機物として、アマニ油吸油量が280j/1G
Of、BET比表積がl OX 10’eMf、比抵抗
がLOX1013Ω・(1m、平均粒径が飄7μ調のシ
リカ微粉末を用い九以外は実施例2と同様の操作を行な
った・ この場合の血液#固時間、血清分離状塾、血清収量をl
klの比較例2の欄に示す。
Comparison 4 #12 As an adsorbent inorganic substance, linseed oil absorption amount is 280J/1G
Of, the BET specific surface area is 1 OX 10'eMf, the specific resistance is LOX 1013 Ω (1 m, and the same operation as in Example 2 was performed except for 9 using fine silica powder with an average particle size of about 7 μm. In this case blood # solidification time, serum separation, serum yield l
It is shown in the column of Comparative Example 2 of kl.

比較例3 吸着性無機物としてアマニ油吸油量が110j/1GO
f%BIE丁晃麦−積が10 X 106d/l。
Comparative Example 3 Linseed oil absorption amount is 110J/1GO as adsorbent inorganic material
f%BIE Ding-Kanmu-product is 10 x 106d/l.

比抵抗がt9x1g4Ω・1、平均粒径がtopmのシ
リカ微粉末tP11い九以外Fi賓施例2と同様の操作
を行なった。
The same operation as in Example 2 was carried out except for using fine silica powder tP11 having a specific resistance of t9×1g4Ω·1 and an average particle size of topm.

この場合の素線J1M1時開、自清分離状l、−清収量
t*10比較例3011に示す。
In this case, the wire J1M1 time open, self-cleaning separation state l, and -clearing yield t*10 are shown in Comparative Example 3011.

比較例4 吸着性無機−2してアマニ油吸油量が!9−710@f
%BICT比表面積# L o X 1 o4ad/f
Comparative Example 4 Absorption of linseed oil with adsorbent inorganic-2! 9-710@f
%BICT specific surface area# L o X 1 o4ad/f
.

比抵抗#LIX101!Ω・1、平均粒**tsp鯛O
シリカ黴粉末を用いえ以外Fi寮施例鵞と同様の操作を
行つえ。
Specific resistance #LIX101! Ω・1, average grain **tsp sea bream O
Carry out the same operations as in the Fi dormitory example except for using silica mold powder.

この場合0一練凝固時岡、自清分離状−%自清収量を表
10此較例4の―に示す。
In this case, the % self-clearing yield after solidification and self-clarification is shown in Table 10 of Comparative Example 4.

Claims (1)

【特許請求の範囲】[Claims] L 血液を遠心分離操作に付して血清と血餅とに分離す
る方決において、血液中に、アマニ油吸油量が20乃至
40s+f/10@f%BIET比麦−績i)i 50
 @ @乃!1GGo6j/f、比抵抗が常温において
I X 1010Ω・1以下である吸着性I#、Il#
I!Jを存在させておくことを特徴とする、tを存在さ
せることを特徴とする特許Ill求の範囲1181項記
1l0−清と血餅との分離方法。
L In the method of separating blood into serum and blood clots by subjecting it to centrifugation, the amount of linseed oil absorbed in the blood is 20 to 40s+f/10@f%BIET ratio i) i 50
@@no! 1GGo6j/f, adsorption I#, Il# with specific resistance of I x 1010 Ω・1 or less at room temperature
I! 1181-110 - A method for separating serum and blood clots, characterized in that J is present and t is present.
JP2859682A 1982-02-23 1982-02-23 Separation of serum and blood clot Pending JPS58144746A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2859682A JPS58144746A (en) 1982-02-23 1982-02-23 Separation of serum and blood clot

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2859682A JPS58144746A (en) 1982-02-23 1982-02-23 Separation of serum and blood clot

Publications (1)

Publication Number Publication Date
JPS58144746A true JPS58144746A (en) 1983-08-29

Family

ID=12252966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2859682A Pending JPS58144746A (en) 1982-02-23 1982-02-23 Separation of serum and blood clot

Country Status (1)

Country Link
JP (1) JPS58144746A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130502A (en) * 1996-05-21 2000-10-10 Kabushiki Kaisha Toshiba Cathode assembly, electron gun assembly, electron tube, heater, and method of manufacturing cathode assembly and electron gun assembly

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5169264A (en) * 1974-11-07 1976-06-15 Corning Glass Works Ketsuekio karuisotomomoisotonibunrisuruhoho
JPS55132957A (en) * 1979-04-04 1980-10-16 Ono Pharmaceut Co Ltd Blood coagulation accelerating vessel
JPS56164609A (en) * 1980-05-21 1981-12-17 Nec Corp Gain adjusting circuit
JPS5716867A (en) * 1980-07-04 1982-01-28 Sankyo Co Ltd Pyrazole derivative and herabicide containing the same as active principle

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5169264A (en) * 1974-11-07 1976-06-15 Corning Glass Works Ketsuekio karuisotomomoisotonibunrisuruhoho
JPS55132957A (en) * 1979-04-04 1980-10-16 Ono Pharmaceut Co Ltd Blood coagulation accelerating vessel
JPS56164609A (en) * 1980-05-21 1981-12-17 Nec Corp Gain adjusting circuit
JPS5716867A (en) * 1980-07-04 1982-01-28 Sankyo Co Ltd Pyrazole derivative and herabicide containing the same as active principle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130502A (en) * 1996-05-21 2000-10-10 Kabushiki Kaisha Toshiba Cathode assembly, electron gun assembly, electron tube, heater, and method of manufacturing cathode assembly and electron gun assembly

Similar Documents

Publication Publication Date Title
Margolis The kaolin clotting time: a rapid one-stage method for diagnosis of coagulation defects
Gärtner Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll).
WO2002073190A1 (en) Method of sorting particulates with different specific gravities
US4255256A (en) Medium for the separation of human blood leucocytes
Linderkamp et al. Geometry of neonatal and adult red blood cells
JP2010515030A (en) Method and apparatus for determining small cell populations in heterogeneous cell populations
JPS58144746A (en) Separation of serum and blood clot
Singh et al. Influence of temperature variation from 5 C to 37 C on aggregation and deformability of erythrocytes
KR102094241B1 (en) Method for Measuring Concentration of Fibrinogen in Blood Sample and Nanoparticles for the Same
Maeda et al. Effect of pH on the velocity of erythrocyte aggregation
Shiga et al. Statistical determination of red cell adhesion to material surface, by varying shear force
Buurman et al. Analysis of buoyant density of canine peripheral blood leukocytes with PVP-Silica (Percoll) density gradients
WO2015119115A1 (en) Erythrocyte sedimentation inhibitor
JPS58195151A (en) Vessel for blood examination
Seike et al. Acceleration of erythrocyte aggregation with in vivo aging
JPS60195452A (en) Device for separating serum
JPS60186760A (en) Blood coagulation accelerator
Horstmann et al. Demonstration of C3b receptor‐like activity and of decay‐accelerating factor‐like activity on rabbit erythrocytes
CN115308010A (en) Antibody protective agent and blood collection tube
JPS60174952A (en) Blood coagulation accelerator
Rassiga-Pidot et al. Paroxysmal nocturnal hemoglobinuria with elevated fetal hemoglobin
JPH0249099B2 (en)
JPS6367861B2 (en)
JPS6367860B2 (en)
Crowley et al. The purification of red cells for transfusion by freeze‐preservation and washing. IV. The use of micropore filtration to reduce the residual HL‐A antigenicity of previously frozen, washed red cells